Bavarian Nordic lancerer aktietilbagekøbsprogram til afdækning af incitamentsprogram
May 27, 2021 01:55 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 27. maj 2021 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet iværksætter et aktietilbagekøbsprogram, hvorunder selskabet vil tilbagekøbe op til 31.747 stk. egne...
Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations
May 27, 2021 01:55 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, May 27, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today the initiation of a new share buy-back program, under which the Company intends to buy back up to 31,747...
Bavarian Nordic offentliggør delårsregnskab for første kvartal 2021
May 27, 2021 01:43 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 27. maj 2021– Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag regnskab samt rapporterede på begivenheder for første kvartal 2021. Administrerende direktør i Bavarian Nordic,...
Bavarian Nordic Announces Interim Results for the First Three Months of 2021
May 27, 2021 01:43 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, May 27, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results and business progress for the first three months of 2021. Paul Chaplin,...
Bavarian Nordic indgår aftale med Dynavax om markedsføring og distribution af HEPLISAV B hepatitis B vaccine i Tyskland
May 27, 2021 01:15 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 27. maj 2021 – Bavarian Nordic A/S (OMX: BAVA) har indgået aftale med Dynavax Technologies Corporation (Nasdaq: DVAX), en biofarmaceutisk virksomhed, der er fokuseret på udvikling...
Bavarian Nordic Announces Marketing and Distribution Agreement with Dynavax to Launch HEPLISAV B® Hepatitis B Vaccine in Germany
May 27, 2021 01:15 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, May 27 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has entered a partnership with Dynavax Technologies Corporation (Nasdaq: DVAX) a biopharmaceutical company focused on...
Ebolavaccine fra Johnson & Johnson og Bavarian Nordic understøtter Verdenssundhedsorganisationens tiltag for at forebygge ebolasmitte i Vestafrika
May 17, 2021 01:30 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 17. maj 2021 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabets partner, Johnson & Johnson vil donere op til 200.000 doser ebolavaccine til at støtte...
Ebola Vaccine Regimen from Johnson & Johnson and Bavarian Nordic Supports World Health Organization in Efforts to Prevent Spread of Ebola in West Africa
May 17, 2021 01:30 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, May 17, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced that its partner Johnson & Johnson is supporting efforts by the World Health Organization (WHO) to...
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
May 12, 2021 14:00 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, May 12, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has today received information about the following transactions of the Company’s shares/related securities by persons...
Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer
May 12, 2021 14:00 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 12. maj 2021 - Bavarian Nordic A/S (OMX: BAVA) har dags dato modtaget oplysninger om følgende transaktioner med selskabets aktie/tilknyttede værdipapirer, foretaget af ledende...